Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Gabardi

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Progress in Transplantation (Aliso Viejo, Calif.)|March 2, 2013
Risk evaluation and mitigation strategies: a focus on the mammalian target of rapamycin inhibitorsSteven Gabardi
Seminars in Nephrology|May 26, 2022
Immunosuppression in the Age of Precision MedicineSteven Gabardi
Transplantation|February 3, 2021
Unraveling the Genomic Architecture of the CYP3A Locus and ADME Genes for Personalized Tacrolimus DosingSteven Gabardi
Pharmacotherapy|September 20, 2011
Understanding risk evaluation and mitigation strategies in organ transplantationSteven Gabardi
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Nonprescription analgesics and their use in solid-organ transplantation: a reviewSteven Gabardi, Linh Luu
The Medical Clinics of North America|March 10, 2005
Drug dosing in chronic kidney diseaseSteven Gabardi, Stuart Abramson
Blood Purification|January 15, 2016
Nephrotoxicity of Natural ProductsMary Nauffal, Steven Gabardi
The Annals of Pharmacotherapy|July 20, 2012
Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitorsSteven Gabardi, Ali Olyaei
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Future immunosuppressive agents in solid-organ transplantationSteven Gabardi, Jeffrey Cerio
Progress in Transplantation (Aliso Viejo, Calif.)|September 15, 2018
Post-Renal Transplantation Outcomes in Elderly Patients Compared to Younger Patients in the Setting of Early Steroid WithdrawalRazan Alsheikh, Steven Gabardi
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Progress in Transplantation (Aliso Viejo, Calif.)|March 2, 2013
Risk evaluation and mitigation strategies: a focus on the mammalian target of rapamycin inhibitorsSteven Gabardi
Seminars in Nephrology|May 26, 2022
Immunosuppression in the Age of Precision MedicineSteven Gabardi
Transplantation|February 3, 2021
Unraveling the Genomic Architecture of the CYP3A Locus and ADME Genes for Personalized Tacrolimus DosingSteven Gabardi
Pharmacotherapy|September 20, 2011
Understanding risk evaluation and mitigation strategies in organ transplantationSteven Gabardi
Progress in Transplantation (Aliso Viejo, Calif.)|October 22, 2004
Nonprescription analgesics and their use in solid-organ transplantation: a reviewSteven Gabardi, Linh Luu
The Medical Clinics of North America|March 10, 2005
Drug dosing in chronic kidney diseaseSteven Gabardi, Stuart Abramson
Blood Purification|January 15, 2016
Nephrotoxicity of Natural ProductsMary Nauffal, Steven Gabardi
The Annals of Pharmacotherapy|July 20, 2012
Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitorsSteven Gabardi, Ali Olyaei
Progress in Transplantation (Aliso Viejo, Calif.)|July 22, 2004
Future immunosuppressive agents in solid-organ transplantationSteven Gabardi, Jeffrey Cerio
Progress in Transplantation (Aliso Viejo, Calif.)|September 15, 2018
Post-Renal Transplantation Outcomes in Elderly Patients Compared to Younger Patients in the Setting of Early Steroid WithdrawalRazan Alsheikh, Steven Gabardi
Pageof 7